CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 36 filers reported holding CYTOSORBENTS CORP in Q2 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $7,000 | -36.4% | 1,800 | -17.6% | 0.00% | – |
| Q3 2019 | $11,000 | +120.0% | 2,185 | +173.1% | 0.00% | – |
| Q2 2019 | $5,000 | -28.6% | 800 | 0.0% | 0.00% | – |
| Q1 2019 | $7,000 | -58.8% | 800 | -61.4% | 0.00% | – |
| Q4 2018 | $17,000 | -37.0% | 2,070 | 0.0% | 0.00% | – |
| Q3 2018 | $27,000 | +92.9% | 2,070 | 0.0% | 0.00% | – |
| Q2 2018 | $14,000 | 0.0% | 2,070 | 0.0% | 0.00% | – |
| Q1 2018 | $14,000 | +75.0% | 2,070 | +72.5% | 0.00% | – |
| Q4 2017 | $8,000 | -96.7% | 1,200 | -96.9% | 0.00% | -100.0% |
| Q3 2017 | $242,000 | +42.4% | 39,100 | -1.3% | 0.00% | +50.0% |
| Q2 2017 | $170,000 | -10.5% | 39,600 | -6.1% | 0.00% | 0.0% |
| Q1 2017 | $190,000 | -19.5% | 42,169 | -2.7% | 0.00% | -33.3% |
| Q4 2016 | $236,000 | -18.9% | 43,319 | -4.6% | 0.00% | -25.0% |
| Q3 2016 | $291,000 | +164.5% | 45,419 | +88.7% | 0.00% | +100.0% |
| Q2 2016 | $110,000 | +18.3% | 24,069 | +2.0% | 0.00% | 0.0% |
| Q1 2016 | $93,000 | -13.1% | 23,600 | +23.0% | 0.00% | 0.0% |
| Q4 2015 | $107,000 | – | 19,181 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 815,869 | $3,141,000 | 0.46% |
| Sargent Investment Group, LLC | 499,010 | $1,921,000 | 0.36% |
| Anson Funds Management LP | 74,440 | $287,000 | 0.33% |
| One68 Global Capital, LLC | 39,241 | $151,000 | 0.33% |
| Granahan Investment Management | 678,618 | $2,613,000 | 0.12% |
| Winning Points Advisors, LLC | 30,000 | $115,000 | 0.07% |
| Avenir Corp | 150,600 | $580,000 | 0.06% |
| HighMark Wealth Management LLC | 10,000 | $38,000 | 0.04% |
| Wealthcare Advisory Partners LLC | 62,279 | $240,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 64,970 | $250,000 | 0.03% |